Table 2 Response to statements regarding knowledge of PICU Chinese Medical Staff on Children with ICU-AW (n%)
Knowledge Statement | Mean ± SD | Do not know | Generally understand | Well understand |
|---|---|---|---|---|
1.Do you know the related concepts of ICU-AW? | 1.68 ± 0.791 | 277(52.3) | 145(27.4) | 108(20.4) |
2.Do you know the clinical manifestations of ICU-AW? | 1.62 ± 0.731 | 279(52.6) | 172(32.5) | 79(14.9) |
3.Do you know how to diagnose ICU-AW? | 1.45 ± 0.626 | 328(61.9) | 164(30.9) | 38(7.2) |
4.Do you know how to evaluate ICU-AW patients? | 1.50 ± 0.643 | 310(58.5) | 177(33.4) | 43(8.1) |
5.Do you know the risk factors for ICU-AW? | 1.58 ± 0.688 | 281(53.0) | 188(35.5) | 61(11.5) |
6.Do you know the preventive measures of ICU-AW? | 1.60 ± 0.703 | 279(52.6) | 184(34.7) | 67(12.6) |
7.Did you know that critically ill children could also develop ICU-AW? | 1.75 ± 0.805 | 253(47.7) | 155(29.2) | 122(23.0) |
8.ICU-AW symptoms are muscle weakness with no clear cause in critically ill patients, clinically manifested as difficulty in weaning, paresis or quadriplegia, decreased reflexes, and muscle atrophy. | 2.42 ± 0.592 | 28(5.3) | 251(47.4) | 251(47.4) |
9.ICU-AW includes polyneuropathy in critically ill patients, myopathy in critically ill patients, and critical neuromuscular diseases. | 2.41 ± 0.593 | 29(5.5) | 256(48.3) | 245(46.2) |
10.The diagnosis of ICU-AW is mainly determined by the Medical Research Council Score (MRC-score). | 2.30 ± 0.562 | 28(5.3) | 315(59.4) | 187(35.3) |
11.Does the MRC-score use the Oxford Muscle Strength Scale to evaluate the six major muscle groups of the body? | 2.32 ± 0.532 | 17(3.2) | 325(61.3) | 188(35.5) |
12.ICU-AW not only prolongs the hospital stay and increases medical costs, but also reduces the patient’s ability to live and survive. | 2.50 ± 0.558 | 16(3.0) | 232(43.8) | 282(53.2) |
13. Braking may be an important risk factor for ICU-AW. | 2.40 ± 0.556 | 18(3.4) | 281(53.0) | 231(43.6) |
14. Early mobilization of ICU patients is the most effective intervention to prevent or mitigate ICU-AW in patients. | 2.51 ± 0.533 | 9(1.7) | 243(45.8) | 278(52.5) |
15. Standard insulin therapy can reduce the incidence and duration of neuromuscular complications, thereby reducing ICU-AW. | 2.29 ± 0.522 | 17(3.2) | 340(64.2) | 173(32.6) |